This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Agenus Inc., Ludwig Institute for Cancer Research Limited, Memorial Sloan Kettering Cancer Center. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 53 
2 out of 530 
2 out of 621 
Years Active: 2019-2024
Title: Rikke Baek Holmgaard: Innovator in Antibody Development
Introduction
Rikke Baek Holmgaard is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology, particularly in the development of antibodies that target critical pathways in cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Holmgaard's latest patents include groundbreaking inventions in the realm of antibodies. The first patent, titled "Antibodies and methods of use thereof," provides antibodies that specifically bind to CTLA-4 and/or PD-1, antagonizing their function. This patent also includes pharmaceutical compositions and kits that comprise these antibodies, nucleic acids encoding them, expression vectors, and host cells for their production. The second patent, "Anti-PD-1 antibodies and methods of use thereof," offers antibodies that specifically bind to human PD-1, also antagonizing its function. This patent similarly encompasses pharmaceutical compositions, nucleic acids, expression vectors, and methods for treating subjects using these antibodies.
Career Highlights
Throughout her career, Holmgaard has worked with notable organizations such as Agenus Inc. and the Ludwig Institute for Cancer Research Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer immunotherapy.
Collaborations
Holmgaard has had the opportunity to work alongside esteemed colleagues, including Marc A Van Dijk and Cornelia Anne Mundt. These collaborations have further enriched her research and development efforts in antibody technology.
Conclusion
Rikke Baek Holmgaard is a distinguished inventor whose work in antibody development is making a substantial impact in the field of cancer treatment. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile